Myriad Genetics, Inc.

Symbol: MYGN

NASDAQ

21.6

USD

Market price today

-7.5210
P/E Ratio
-0.4011
PEG Ratio
1.94B
MRK Cap
0.00%
DIV Yield

Myriad Genetics, Inc. (MYGN) Financial Statements

Q: What is Myriad Genetics, Inc. (MYGN) total assets?

Myriad Genetics, Inc. (MYGN) total assets is .

Download

Annual Quarterly

Linear Log

On the chart you can see the default numbers in dynamics for Myriad Genetics, Inc. (MYGN). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Annual Quarterly

10Y 20Y 30Y 40Y

Balance Sheet

Diving into the fiscal trajectory of Myriad Genetics, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln USD Growth	2021	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	114.9	339.8	136.9	136.9	180.6	150.7	159	144.8	270.6	531.1	454.2	346.5	403.2	316.9	328.7	308.3	227.7	113.8	115.4	72.8	73.1	127.2	80.5	9.9	14.6	15.7	13.2
balance-sheet.row.short-term-investments	58	81.4	43.7	43.7	69.7	48.3	90.5	80.7	121.6	268.2	254.2	293.8	310.4	253.3	91	164.9	129.2	64.3	31.4	11.2	12	91.3	24.3	4.5	0	0	0
balance-sheet.row.net-receivables	101.6	91.3	138.6	138.6	102.1	111.3	95	87.7	98.7	97.7	63.1	50.3	48.1	45.3	45.4	32.5	22.2	18.4	14.5	22.3	7.5	5.8	2.8	3.2	0.6	0.5	0
balance-sheet.row.inventory	20.1	15.3	31.4	31.4	34.3	42.2	38.3	25.1	23.9	5	11.6	5.7	-399.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	20.4	38.4	41.7	46.4	9.4	12.9	22.2	26	27	9	7.3	417.9	488.4	4	3.1	2.5	2.3	3.3	7.3	7.7	4.8	4.2	2.7	0.6	16.5	32.4	37.4
balance-sheet.row.total-current-assets	274.6	484.8	348.6	348.6	326.4	317.1	314.5	283.6	400.1	634.7	530.6	479.3	540.6	366.2	377.3	343.3	252.3	135.6	137.2	102.8	85.4	137.2	85.9	13.7	31.7	48.6	50.6
balance-sheet.row.property-plant-equipment-net	187.3	125.3	57.3	57.3	43.2	51.1	58.3	67.2	34.6	27.6	24.2	23.1	23.3	22.6	30	24.9	19.8	18.5	17.3	18.7	15.4	12.7	11.3	10	12.4	12	9.4
balance-sheet.row.goodwill	286.8	239.2	417.2	417.2	318.6	316.1	195.3	177.2	169.2	56.9	56.9	56.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	379.7	404.1	684.7	684.7	455.2	491.6	227.5	192.6	205.3	13.3	15.7	16.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	666.5	643.3	1101.9	1101.9	773.8	807.7	422.8	369.8	374.5	70.2	72.6	72.8	-85.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	54.8	59	54.9	54.9	30.7	48.5	79.9	40.6	84.1	158.7	113.7	70.9	85.2	75.4	91.3	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	9.6	36.6	36.2	35.7	28	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	15.5	8.3	0	-1214.1	0	0	5	5	-79.1	-124.1	-86.7	-70.9	2.1	2.3	0.7	3.9	4.5	4.9	33.8	61.3	56.6	22.2	9.2	29.9	23.3	15.5	19.6
balance-sheet.row.total-non-current-assets	924.1	835.9	1214.1	1214.1	847.7	907.3	566	482.6	423.7	169.1	160	131.5	53.3	100.3	122	28.8	24.3	23.4	51.2	80	72	34.9	20.4	39.9	35.7	27.5	29
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1198.7	1320.7	1562.7	1562.7	1174.1	1224.4	880.5	766.2	823.8	803.8	690.6	610.8	593.8	466.4	499.3	372.1	276.6	159	188.4	182.8	157.4	172.1	106.4	53.6	67.4	76.1	79.6
balance-sheet.row.account-payables	28.8	29.6	33.3	33.3	26	22	21.1	21.1	23.1	18.1	10.1	11.4	8.9	14.2	24.9	15.8	11.8	11.9	7.9	11.5	9.5	9.7	4.3	2.9	5.1	2.6	2.2
balance-sheet.row.short-term-debt	14.1	13	78.9	78.9	68.3	65.6	0	0	0	0	0	9.6	0	0	0	0	0	0	0	0	3.6	0	0	0	0.1	0.3	0.3
balance-sheet.row.tax-payables	4.8	4	3	3	4.3	7.1	2.8	3.8	277.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	130.9	79.3	233.5	233.5	9.3	99.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.5
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	93.7	156.5	3.4	82.3	5.3	127.3	49.5	46.1	56.4	44.3	32.8	21.6	27.4	18	46.8	15.6	14.9	10.1	5.9	4.9	1	3.1	24.4	2.4	4.7	6.9	6.5
balance-sheet.row.total-non-current-liabilities	175.7	148.6	356	356	107	229.1	60.1	35.4	24.2	10.7	10	9.6	8.8	14.2	26.9	16.1	11.9	13.1	9.1	14.4	23.9	29.5	4.3	0.1	5.2	0.1	0.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	-9.6	-8.8	-14.2	-26.9	-16.1	-11.9	-13.1	-9.1	-14.4	-23.9	-29.5	-4.3	0	-5.2	0	0
balance-sheet.row.capital-lease-obligations	145	92.3	70.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	312.9	352.9	473.8	473.8	209.2	446.6	132.4	104.1	104.8	75.2	55	44	36.3	32.2	73.7	31.7	26.8	23.3	15.1	19.3	28.5	32.6	28.7	5.4	9.9	9.9	9.4
balance-sheet.row.preferred-stock	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.8	0.8	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.8	0.8	0.9	0.9	1	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.1	0	0	0
balance-sheet.row.retained-earnings	-366.2	-254.2	25.6	25.6	52.8	-68.4	-73.2	-77	2	30.9	-12.7	-38.6	-10.5	-119.9	-204.6	-252.4	-217.4	-179.2	-139.3	-98.7	-73.8	-59.8	-52.7	-43.9	-33.9	-24.1	-14.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	-8.9	-5.1	-5.4	-5.4	-4	-5.5	-9.5	-7	-1.5	-0.4	-0.2	0.2	0.1	2.8	-0.2	-0.4	-0.7	-0.5	-0.2	0.7	0.3	0.4	-0.1	-0.3	0	0	0
balance-sheet.row.other-total-stockholders-equity	1260.1	1226.3	1068	1068	915.4	851.4	830.1	745.4	717.8	697.3	647.7	604.4	567	550.4	630	592.7	467.6	315.1	312.5	261.2	202.1	198.8	130.2	92.3	91.4	90.3	85.1
balance-sheet.row.total-stockholders-equity	885.8	967.8	1088.9	1088.9	964.9	778.2	748.1	662.1	719	728.6	635.7	566.8	557.6	434.2	425.7	340.4	249.8	135.7	173.3	163.5	128.9	139.6	77.7	48.2	57.5	66.2	70.2
balance-sheet.row.total-liabilities-and-stockholders-equity	1198.7	1320.7	1562.7	1562.7	1174.1	1224.4	880.5	766.2	823.8	803.8	690.6	610.8	593.8	466.4	499.3	372.1	276.6	159	188.4	182.8	157.4	172.1	106.4	53.6	67.4	76.1	79.6
balance-sheet.row.minority-interest	0	0	0	0	0	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	-	-	-	1088.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	112.8	140.4	98.6	98.6	100.4	96.8	170.4	121.3	205.8	427	367.9	364.6	395.5	328.7	182.3	164.9	129.2	64.3	31.4	11.2	12	91.3	24.3	4.5	0	0	0
balance-sheet.row.total-debt	145	92.3	233.5	233.5	9.3	99.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.8
balance-sheet.row.net-debt	88.1	-166.1	140.3	140.3	-101.6	-3.3	-68.5	-64.1	-64.8	-104.1	-86.4	-52.7	-92.8	-63.5	-237.7	-143.4	-98.6	-49.5	-84	-61.6	-61.1	-35.9	-56.2	-5.4	-14.5	-15.3	-12.4

Cash Flow Statement

The financial landscape of Myriad Genetics, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln USD Growth	2021	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
cash-flows.row.net-income	-112	-27.2	4.6	4.6	131	21.8	125.3	80.2	176.2	147.1	112.2	100.7	152.3	84.6	47.8	-35	-38.2	-40	-40.6	-24.8	-14	-7.2	-8.7	-10	-9.8	-9.2	-5.9
cash-flows.row.depreciation-and-amortization	52.7	62.8	73	73	54.4	48.3	26.7	25	13.8	8.9	9.1	7.2	7.1	9.4	8.8	7.5	6.9	6.1	5.8	5.3	4.5	3.7	3.3	3.2	3.3	2.5	1.6
cash-flows.row.deferred-income-tax	-31.9	-34.7	13.1	13.1	-23.7	2.5	15.7	1.7	7.5	8.2	34.2	40.4	-28.1	0.5	0	0	0.2	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	38.1	36.3	33.5	33.5	27.1	29.9	31.6	45.7	27.1	26.6	26.3	25.1	22.8	25.7	0	0	-0.2	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-101.5	120.4	-37.1	-37.1	-21.6	-36.6	-65.4	-40.7	-60	-41	-28.8	38.5	-27.4	-54.1	16.9	-11.2	-1.4	6.1	1.9	-27.3	-7.3	-0.7	22.1	-7.5	-0.6	-0.1	5.6
cash-flows.row.account-receivables	-10.3	-8.8	-18.2	-18.2	-39.2	-41.4	-39.2	-34.4	-24.4	-67.2	-34.9	-15	-21.7	-19.9	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-2.9	1.6	8	8	7.9	-1.2	-14.6	-0.8	-15.8	6.6	-3.4	0.2	-0.5	-21.5	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	-3.5	9.2	1.1	1.1	4	-3	-11.4	-3.1	-1.5	8	-1.2	0.3	-5.3	-10.7	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-84.8	118.4	-28	-28	5.7	9	-0.2	-2.4	-18.3	11.6	10.9	53	0	-2	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-non-cash-items	48.3	-139.4	-3.4	-3.4	-51.3	40.3	32.4	28.6	25.6	24.1	-11.1	-81.2	28.4	17.9	30.3	12.7	4.7	4.5	2	0.4	0.5	0.4	0.5	0.2	0.1	0.2	0.1
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-45.3	-18	-8.6	-8.6	-8.4	-6.1	-5	-23.9	-14.3	-11.4	-10.2	-5.8	0	-7.5	-13.7	-11.4	-7.7	-6.7	-3.9	-8	-6.9	-5.3	-4.6	-4	-3.2	-4.7	-6.4
cash-flows.row.acquisitions-net	-57.2	379.1	-278.5	-278.5	8.4	-216.1	-37	-20.1	-223.5	-5	-0.8	-79.4	0	7.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0
cash-flows.row.purchases-of-investments	-103.2	-147.8	-78.5	-78.5	-80.9	-87.5	-164.5	-80.7	-161.8	-443.8	-396.1	-425.2	-477.6	-308.6	-191.7	-197.8	-165.5	-44.6	-52.7	-51.8	-89.8	-249.3	-24	-291.7	-840.6	-582.8	-622.2
cash-flows.row.sales-maturities-of-investments	128.2	61.1	79.2	79.2	77.7	163.4	115.1	165.6	381.9	384.6	385.2	456.1	52.2	111.8	174.4	162.5	100.5	71	58.6	50.7	137.2	172.2	25	300.2	841.1	592.2	569.6
cash-flows.row.other-investing-activites	0	0	0	0	-8.4	0	0	0	0	0	-17.1	-0.1	348.7	-9.6	-0.3	0	-0.1	-0.1	-0.1	-2.9	-2.5	-2.7	-0.8	0	0	-0.1	0
cash-flows.row.net-cash-used-for-investing-activites	-77.5	274.4	-286.4	-286.4	-11.6	-146.3	-91.4	40.9	-17.7	-75.6	-38.9	-54.4	-76.7	-206.3	-31.3	-46.7	-72.8	19.5	1.9	-12	38.1	-85.1	-4.3	4.5	-2.7	4.7	-59
cash-flows.row.debt-repayment	0	-226.4	-115	-115	-143	-305	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	6.3	91.8	8.7	8.7	36.9	6	0	30	0	0	0	25.1	22.3	84.2	21.9	117.5	149.9	2.5	51.3	59	3.4	68.6	38	0.6	0.6	4.6	59.2
cash-flows.row.common-stock-repurchased	0	0	-50	-50	0	-31.6	-162.6	-210.7	-287.7	-146.3	-128.5	-200.5	-71.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	-340	-340	0	-403	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-14.3	-16	678.6	338.6	11.1	805.4	94.3	3.4	75.9	65.7	59.2	58.8	0	-136.1	0	0	0	0	0	0	0	0	0	-0.2	-0.4	-0.3	-0.3
cash-flows.row.net-cash-used-provided-by-financing-activities	-8	-150.6	182.3	182.3	-95	71.8	-68.3	-177.3	-211.8	-80.6	-69.2	-116.6	-49.1	-51.9	21.9	117.5	149.9	2.5	51.3	59	3.4	68.6	38	0.4	0.2	4.3	58.9
cash-flows.row.effect-of-forex-changes-on-cash	-0.6	-0.6	2.7	2.7	-0.8	2.2	-2.2	-4.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	-14.6	-15.6	-13.2
cash-flows.row.net-change-in-cash	-192.4	141.4	-17.7	-17.7	8.5	33.9	4.4	-0.7	-39.3	17.7	33.7	-40.2	29.3	-174.2	94.3	44.9	49.1	-1.3	22.4	0.5	25.1	-20.3	50.8	-9.2	-24.1	-13.2	-11.9
cash-flows.row.cash-at-end-of-period	66.4	258.4	93.2	93.2	110.9	102.4	68.5	64.1	64.8	104.1	86.4	52.7	92.8	63.5	237.7	143.4	98.6	49.5	84	61.6	61.1	35.9	56.2	5.4	0	0	0
cash-flows.row.cash-at-beginning-of-period	258.8	117	110.9	110.9	102.4	68.5	64.1	64.8	104.1	86.4	52.7	92.8	63.5	237.7	143.4	98.6	49.5	50.8	61.6	61.1	35.9	56.2	5.4	14.6	24.1	13.2	11.9
cash-flows.row.operating-cash-flow	-106.3	18.2	83.7	83.7	115.9	106.2	166.3	140.5	190.2	173.9	141.8	130.8	155.1	84	103.7	-25.9	-28	-23.3	-30.9	-46.5	-16.3	-3.8	17.2	-14.1	-7	-6.6	1.4
cash-flows.row.capital-expenditure	-45.3	-18	-8.6	-8.6	-8.4	-6.1	-5	-23.9	-14.3	-11.4	-10.2	-5.8	0	-7.5	-13.7	-11.4	-7.7	-6.7	-3.9	-8	-6.9	-5.3	-4.6	-4	-3.2	-4.7	-6.4
cash-flows.row.free-cash-flow	-151.6	0.2	75.1	75.1	107.5	100.1	161.3	116.6	175.9	162.5	131.7	125	155.1	76.5	90.1	-37.3	-35.7	-30	-34.8	-54.6	-23.2	-9	12.5	-18.1	-10.2	-11.3	-5

Income Statement Row

Myriad Genetics, Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of MYGN is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln USD Growth	2021	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	678.4	690.6	851.1	851.1	772.6	771.4	753.8	723.1	778.2	613.2	496	402.1	362.6	326.5	333.6	157.1	114.3	82.4	56.6	64.3	53.8	45.2	34	25.3	23.2	15.2	6.6
income-statement-row.row.cost-of-revenue	202	197.6	201	201	177.2	171.2	157.3	147.4	109.2	79.6	64.7	46.7	44.3	43.3	32.3	30.8	27.6	20.3	13.8	12.6	10.7	7.4	0.7	-0.1	-1.9	-2.2	-1.6
income-statement-row.row.gross-profit	476.4	493	650.1	650.1	595.4	600.2	596.5	575.7	669	533.5	431.3	355.4	318.4	283.3	301.3	126.3	86.6	62.1	42.9	51.8	43.1	37.8	33.3	25.4	25.1	17.4	8.2
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.6	139.3	1.2	1.2	-0.4	-2.5	1.2	0.3	-2	-0.2	-0.4	0	0	0	0	0	0	0	0	0	0	0	3.3	3.2	3.3	2.5	1.6
income-statement-row.row.operating-expenses	600.1	681.7	641.4	641.4	537.9	550.8	429.7	441.5	394.6	305.5	251	197.6	183.3	156.8	263.2	174	132.2	102.8	85.5	79.1	61.8	50.9	44.9	37.8	38.1	29.9	17.1
income-statement-row.row.cost-and-expenses	802.1	879.3	842.4	842.4	715.1	722	587	588.9	503.8	385.2	315.7	244.3	227.6	200.1	295.5	204.9	159.9	123.2	99.3	91.7	72.5	58.3	45.6	37.7	36.2	27.7	15.5
income-statement-row.row.interest-income	2.6	0.7	3.2	3.2	1.8	1.2	0.9	0.4	5.4	5.5	4.6	2.2	5.7	12.5	13.7	12.1	7.4	2.8	0	2.9	5.4	0	0	0	0	0	0
income-statement-row.row.interest-expense	3.2	6.6	12	12	3.2	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-16.9	-8.4	0.1	0.1	60.8	-1.7	1.2	0.3	-2	-0.2	-0.4	-0.4	0.1	-2.5	-3.3	0.7	0	-2	0	0	-0.2	-0.3	-0.4	12.4	3.2	3.3	3.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.6	139.3	1.2	1.2	-0.4	-2.5	1.2	0.3	-2	-0.2	-0.4	0	0	0	0	0	0	0	0	0	0	0	3.3	3.2	3.3	2.5	1.6
income-statement-row.row.total-operating-expenses	-16.9	-8.4	0.1	0.1	60.8	-1.7	1.2	0.3	-2	-0.2	-0.4	-0.4	0.1	-2.5	-3.3	0.7	0	-2	0	0	-0.2	-0.3	-0.4	12.4	3.2	3.3	3.1
income-statement-row.row.interest-expense	3.2	6.6	12	12	3.2	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	55.9	62.8	73	73	54.4	48.3	26.7	25	13.8	8.9	9.1	7.2	7.1	9.4	8.8	7.5	6.9	6.1	5.8	5.3	4.5	3.7	3.3	3.2	3.3	2.5	1.6
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-123.7	-48.7	7.6	7.6	118.7	49.4	166.8	134.2	274.4	228	180.3	157.8	135.1	126.5	38.1	-47.7	-45.6	-40.7	-42.6	-27.3	-18.7	-13.1	-11.5	-12.4	-13	-12.5	-8.9
income-statement-row.row.income-before-tax	-140.6	-57.1	0.2	7.7	116.9	42.9	168.9	134.9	277.9	233.3	184.5	159.7	140.8	136.4	48.5	-35	-38.2	-40	-40.6	-24.4	-13.5	-6.6	-8.7	-10	-9.8	-9.2	-5.9
income-statement-row.row.income-tax-expense	-28.6	-29.9	-4.4	-4.4	-13.9	21.3	43.6	54.7	101.6	86.1	72.4	58.9	-11.5	0.2	0.6	35	-7.4	-0.8	-2	0.4	0.5	0.6	8.7	10	9.8	9.2	5.9
income-statement-row.row.net-income	-112	-27.2	4.6	4.6	131	21.8	125.3	80.2	176.2	147.1	112.2	100.7	152.3	84.6	47.8	-35	-38.2	-40	-40.6	-24.8	-14	-7.2	-8.7	-10	-9.8	-9.2	-5.9

Similar Stocks

Frequently Asked Question

What is Myriad Genetics, Inc. (MYGN) total assets?

Myriad Genetics, Inc. (MYGN) total assets is 1198700000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.689.

What is company free cash flow?

The free cash flow is -1.692.

What is enterprise net profit margin?

The net profit margin is -0.374.

What is firm total revenue?

The total revenue is -0.370.

What is Myriad Genetics, Inc. (MYGN) net profit (net income)?

The net profit (net income) is -112000000.000.

What is firm total debt?

The total debt is 145000000.000.

What is operating expences number?

The operating expences are 600100000.000.

What is company cash figure?

Enretprise cash is 0.000.